Interview with LGM Pharma’s CEO, Prasad Raje

Published on: 

Key Learning Objectives:

  • LGM Pharma reports strong revenues in its first year of CDMO operations and continued growth in its API Sourcing business
  • Offering API sourcing and CDMO services, plus Analytical Testing and new Drug Product R&D services, addresses the comprehensive needs of customers as LGM promotes its customer-centric strategies for growth.
  • LGM Pharma elevated its API sourcing network with the 2020 acquisition of NexGen Pharma’s CDMO business – enabling the one company to provide comprehensive services.